Zoledronic acid has no effect on knee pain or bone marrow lesions in knee OA after two years

June 15, 2018, European League Against Rheumatism

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) show that a one-yearly infusion of zoledronic acid (ZA) did not significantly reduce knee pain or bone marrow lesion (BML) size overall in knee osteoarthritis patients over two years. However, it may have symptomatic benefit in milder disease.

Osteoarthritis is a common condition that makes a person's joints stiff and painful, particularly in the morning. One of the causes is thinning of the cartilage within the joints, which allows the bones to rub against each other. Joint swelling and are frequent symptoms. It is the most common of all the different types of arthritis, and typically becomes more common as people get older.

"Osteoarthritis currently affects over 40 million Europeans and has a significant societal impact on sufferers and economic burden on health systems, this is only set to escalate in a rapidly ageing population," said Professor Thomas Dörner, Chairperson of the Abstract Selection Committee, EULAR. "There are very limited effective treatment options for the disease and lesions remain an important therapeutic target."

Promising results from a pilot study previously conducted in 59 adults showed a single infusion of reduced pain and BML size in knee over six months. The results presented today were from a multicentre, randomised, double-blinded, placebo-controlled trial that was designed to assess whether these improvements could be reproduced in a larger cohort over two years.

"It is disappointing that our results have not replicated the positive findings of the initial pilot study," said Professor Graeme Jones, Menzies Institute for Medical Research (study author). "However, there may be a role for zoledronic acid to relieve symptoms in patients with mild osteoarthritis."

Results showed that after 24 months, there were no significant changes in knee pain (WOMAC pain score: -37.5 vs -11.7, p=0.205; VAS pain score: -11.5 vs -16.8, p=0.17), WOMAC function score (-134.9 vs -159.2, p=0.65), or knee BML size (-33.5mm2 vs—11.7mm2, p=0.68) between the zoledronic acid group and placebo group respectively. However, pre-specified analyses consistently showed that ZA was more effective than placebo in patients without radiographic osteoarthritis (joint space narrowing (JSN) Grade 0) on changes in WOMAC pain (-88.3 vs -42.6, p=0.21), VAS pain (-21.8 vs -8.3, p=0.11), WOMAC function (-296.9 vs -78.5, p=0.06) and BML size (-67.4 vs 98.2, p=0.14). Adverse events were more frequent in the ZA group, primarily flu-like symptoms and musculoskeletal pain and stiffness.

The study was a multicentre, randomised, double-blinded, placebo-controlled trial over two years. There were 223 patients enrolled in the study who were 50 years or older and who had significant ‡ and MRI-detected knee BML. Severe knee osteoarthritis patients were excluded. The mean age of participants was 62 and 52% were female. The baseline mean WOMAC scores for pain and function were 200/500 and 657/1700 respectively. The mean VAS† was 51/100 and the median BML size was 489.6mm. Patients were randomized to receive either ZA or placebo once-yearly.

Explore further: Depressive symptoms associated with disease severity in patients with knee osteoarthritis

More information: Abstract number: OP0016 , DOI: 10.1136/annrheumdis-2018-eular.1539

Related Stories

Depressive symptoms associated with disease severity in patients with knee osteoarthritis

June 14, 2018
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that among individuals with radiographic knee osteoarthritis (OA), decreased physical performance and greater ...

Is knee pain linked to depression?

March 23, 2018
In the U.S., about 13 percent of women and 10 percent of men aged 60 or older have knee pain due to osteoarthritis (OA). Osteoarthritis occurs when a joint becomes inflamed, usually because the protective cartilage and other ...

Spironolactone no benefit for knee OA in older adults

June 3, 2016
(HealthDay)—For older adults with knee osteoarthritis (OA), spironolactone is not associated with improvements in symptoms, physical function, or health-related quality-of-life, according to a study published in the May ...

Are older adults with knee pain less active than the general population?

February 22, 2018
A new Arthritis Care & Research study found that moderate-to-vigorous physical activity levels are similarly low in older adults with symptomatic knee osteoarthritis and those from the general population without osteoarthritis ...

Minimally invasive treatment reduces knee pain and disability from osteoarthritis

March 19, 2018
A nonsurgical treatment could improve quality of life for patients with knee pain due to osteoarthritis, according to new research presented today at the Society of Interventional Radiology's 2018 Annual Scientific Meeting.

Findings do not support steroid injections for knee osteoarthritis

May 16, 2017
Among patients with knee osteoarthritis, an injection of a corticosteroid every three months over two years resulted in significantly greater cartilage volume loss and no significant difference in knee pain compared to patients ...

Recommended for you

Potential arthritis treatment prevents cartilage breakdown

November 28, 2018
Osteoarthritis, a disease that causes severe joint pain, affects more than 20 million people in the United States. Some drug treatments can help alleviate the pain, but there are no treatments that can reverse or slow the ...

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Defense against joint degeneration

October 30, 2018
During cartilage development, chondrocytes secrete the extracellular matrix (ECM) and embed within the same environment. During progressive joint disease, such as osteoarthritis (OA), dysregulation of the process can lead ...

Becoming more sensitive to pain increases the risk of knee pain not going away

October 30, 2018
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated ...

Ground-breaking discovery finds new link between autoimmune diseases and a gut bacterium

October 29, 2018
Could microbes in our guts be sending out the wrong message? Queen's University Belfast researchers have, for the first time, found a specific microbe in the gut that pumps out protein molecules that mimic a human protein, ...

Research shows diet has little influence on precursor to gout

October 11, 2018
Dietary factors have a far smaller influence on urate levels (a precursor to gout) than previously envisaged, new University of Otago research reveals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.